Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
2
×
Tags
boston blog main
boston top stories
2
×
clinical trials
life sciences
national blog main
national top stories
new york
2
×
new york blog main
new york top stories
abbvie
acorda therapeutics
amgen
ampyra
apokyn
apomorphine
cholesterol
dalfampridine
data
duopa
inbrija
inclisiran
ldl
mark timney
mt sinai hospital
mylan
parkinson's disease
paul matteis
pcsk9
peter wijngaard
praluent
prashant vaishnava
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
stiel
sunovion pharmaceuticals
the medicines co.
What
drug
meant
2
×
aces
acorda
announced
approved
big
ceo
cholesterol
cope
disease
episodes
fda
flexible
friday
gets
help
inclisiran
key
late
looms
lowering
medco
medications
medicine
medicines
nasdaq
new
nod
open
parkinson’s
passed
patients
pricing
rival
stop
taken
test
treatment
twice
Language
unset
Current search:
meant
×
photo
×
" boston top stories "
×
" new york "
×
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms